Literature DB >> 10483137

[Causes of death (1983-1997) in patients infected with human immunodeficiency virus by contaminated blood coagulation factor products: report of the clinical study group on prevention and treatments of HIV infection].

K Fukutake1, Y Ueda, S Tatsunami, A Ajisawa, S Oka, J Takamatsu, M Taki, A Shirahata.   

Abstract

Our group conducted a national survey of patients who had died of acquired immunodeficiency syndrome (AIDS) after being infected with human immunodeficiency virus type 1 (HIV-1) by contaminated blood coagulation factor products. A total of 1446 hospitals, clinics, and other health-care institutions throughout Japan were enrolled in the study, which was supported by the Japanese government Ministry of Health and Welfare with a health sciences grant for research on HIV/AIDS. Of the 1434 registered patients who had been infected with HIV-1 by contaminated blood coagulation factor products, 493 (34%) had died as of Oct. 30, 1997. Most were hemophiliacs. The average CD4+ cell count was 25/microliter for the 398 who died of complications from AIDS, compared to an average of 158/microliter for those who died of other causes. Pneumocystis carinii pneumonia, cytomegalovirus infection, and atypical mycobacterial disease were the main causes of death in patients with AIDS. The annual death rate for AIDS patients in Japan dropped dramatically in 1997, 1 year later than a similar trend observed in the United States. The introduction and widespread adoption of new and effective drugs and treatment regimens for HIV-1 and opportunistic infections will be essential life-saving measures.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10483137

Source DB:  PubMed          Journal:  Rinsho Ketsueki        ISSN: 0485-1439


  3 in total

1.  The number of people in Japan with coagulation disorders: 2001 update.

Authors:  Shinobu Tatsunami; Masashi Taki; Akira Shirahata; Junich Mimaya; Kaneo Yamada
Journal:  Int J Hematol       Date:  2003-01       Impact factor: 2.490

2.  Determination of pharmacokinetic parameters of stavudine in Japanese patients infected with HIV-1, using a Gaussian-like input rate function.

Authors:  S Tatsunami; A Ito; K Kawata; R Kuwabara; K Yamada
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2001 Jan-Jun       Impact factor: 2.441

3.  Current status of Japanese HIV-infected patients with coagulation disorders: coinfection with both HIV and HCV.

Authors:  Shinobu Tatsunami; Junichi Mimaya; Akira Shirahata; Jiří Zelinka; Ivana Horová; Jugo Hanai; Yutaka Nishina; Katsumi Ohira; Masashi Taki
Journal:  Int J Hematol       Date:  2008-08-02       Impact factor: 2.490

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.